Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The initiative is focused on a problem that continues to plague cancer outcomes in India
The expansion includes a larger technical and service team and increased local procurement
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
The inspection concluded with one minor observation in Form 483
The new centre brings advanced corneal procedures pioneered in India
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
